New York Life Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4M Buy
133,748
+13,220
+11% +$1.18M 0.1% 184
2025
Q4
$9.52M Buy
120,528
+1,962
+2% +$154K 0.08% 205
2025
Q3
$9.48M Sell
118,566
-2,892
-2% -$247K 0.08% 207
2025
Q2
$11M Buy
121,458
+1,330
+1% +$121K 0.1% 185
2025
Q1
$11.3M Sell
120,128
-1,308
-1% -$117K 0.11% 163
2024
Q4
$11M Sell
121,436
-790
-0.6% -$75.4K 0.11% 171
2024
Q3
$12.7M Sell
122,226
-3,197
-3% -$326K 0.12% 161
2024
Q2
$12.2M Buy
125,423
+838
+0.7% +$77.3K 0.12% 164
2024
Q1
$11.2M Sell
124,585
-4,321
-3% -$366K 0.11% 170
2023
Q4
$10.3M Buy
128,906
+336
+0.3% +$25.3K 0.11% 175
2023
Q3
$9.14M Sell
128,570
-1,187
-0.9% -$88.8K 0.1% 191
2023
Q2
$10M Sell
129,757
-1,528
-1% -$118K 0.1% 175
2023
Q1
$9.87M Buy
131,285
+31
+0% +$2.31K 0.11% 190
2022
Q4
$10.3M Buy
131,254
+35
+0% +$2.62K 0.12% 184
2022
Q3
$9.22M Sell
131,219
-2,121
-2% -$166K 0.11% 192
2022
Q2
$10.7M Buy
+133,340
New +$10.4M 0.12% 168
2015
Q4
Sell
-6,600
Closed -$419K 85
2015
Q3
$419K Hold
6,600
0.04% 104
2015
Q2
$432K Buy
6,600
+200
+3% +$13.6K 0.05% 103
2015
Q1
$444K Hold
6,400
0.05% 102
2014
Q4
$443K Sell
6,400
-800
-11% -$54K 0.05% 106
2014
Q3
$470K Hold
7,200
0.08% 89
2014
Q2
$491K Buy
7,200
+3,500
+95% +$235K 0.08% 83
2014
Q1
$240K Hold
3,700
0.05% 95
2013
Q4
$241K Sell
3,700
-100
-3% -$6.4K 0.06% 78
2013
Q3
$225K Hold
3,800
0.07% 76
2013
Q2
$218K Buy
+3,800
New +$226K 0.07% 75

Other funds holding CL

New York Life Investment Management's CL Position: Q1 2026 in Review

New York Life Investment Management increased its Colgate-Palmolive (CL) stake by 11% in Q1 2026, buying an estimated $1.18M and bringing the position to 133,748 shares worth $11.4M. The position accounts for 0.1% of the portfolio, ranked #184.

New York Life Investment Management first reported a position in CL in Q2 2013 and has held it in 26 quarters since. The position peaked at $12.7M in Q3 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • New York Life Investment Management held 133,748 shares of Colgate-Palmolive worth $11.4M as of Q1 2026.
  • New York Life Investment Management bought 13,220 Colgate-Palmolive shares in Q1 2026, an estimated $1.18M.
  • Colgate-Palmolive made up 0.1% of New York Life Investment Management's portfolio in Q1 2026, its #184 holding.
  • New York Life Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
  • New York Life Investment Management's Colgate-Palmolive position peaked at $12.7M in Q3 2024.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.